Immuneering Corporation (IMRX) Tops Q2 EPS by 10c
Tweet
Share
E-mail
Get Alerts IMRX Hot Sheet
Join SI Premium – FREE
Immuneering Corporation (NASDAQ: IMRX) reported Q2 EPS of ($0.43), $0.10 better than the analyst estimate of ($0.53).
For earnings history and earnings-related data on Immuneering Corporation (IMRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- JPMorgan Downgrades Anima Holding SA (ANIM3:BZ) to Neutral
- JPMorgan Upgrades YDUQS Participacoes SA (YDUQ3:BZ) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
